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Abstract 
Alcohol abuse leads to serious health problems with no effective treatment available. 
Recent evidence suggests a role for ras-specific guanine-nucleotide releasing factor 
2 (RASGRF2) in alcoholism. Rasgrf2 is a MAPK/ERK activating protein, which has 
been linked to neurotransmitter release and monoaminergic receptor adaptations. 
Rasgrf2 knock out (KO) mice do not develop a dopamine response in the nucleus 
accumbens after an alcohol challenge and show a reduced consumption of alcohol. 
The present study aims to further characterize the role of Rasgrf2 in dopaminergic 
activation beyond the nucleus accumbens following alcohol treatment. Using in-vivo 
microdialysis we found that alcohol increases dopamine levels in the dorsal striatum. 
This increase was absent in Rasgrf2 KO mice. There was no difference in 
expression of dopamine transporter (DAT), dopamine receptor regulating factor 
(DRRF), or dopamine D2 receptor (DRD2) mRNA in the brain between Rasgrf2 KO 
and WT mice. After sub-chronic alcohol treatment, DAT and DRRF, but not DRD2 
mRNA expression in Rasgrf2 KO mice decreased relative to WT levels. Brain 
adaptations were positively correlated with blood expression levels. These data 
suggest a Rasgrf2 controls dopaminergic signaling and adaptations to alcohol also 
beyond the nucleus accumbens.  
 
 
Keywords:  
Rasgrf2, dopamine, alcohol, microdialysis, dopamine transporter, dopamine receptor 
regulating factor, D2 receptor 
  
3 
 
1. Introduction 
Alcohol use develops into addiction in a significant number of people. Alcohol abuse 
leads to serious health problems in approximately 10-20% of chronic alcohol 
consumers and results in 2.5 million deaths each year [1]. Although significant 
heritability estimates of alcohol addiction have been identified [2], underlying genetic 
influences are not surfacing as quickly [3,4]. Recent evidence suggests a role of the 
ras-specific guanine-nucleotide releasing factor 2 (RASGRF2) gene in alcoholism 
[5]. The study reports RASGRF2 in the regulation of mesolimbic dopamine activity 
which ultimately impacts upon reward response and alcohol consumption.  
 Rasgrf2 is enriched at synaptic sites of the CNS. It is a calmodulin (CaM) 
associated guanine nucleotide exchange factor and becomes active in the presence 
of CaM. Activation of Rasgrf2 in turn activates the RAS protein which is known to be 
involved in the MAPK/ERK signal transduction pathway [6] and the regulation of 
signalling pathways in cells. Rasgrf2, as a MAPK/ERK activating protein, has 
therefore been linked to neurotransmitter release [7]. The RAS-MAPK/ERK pathway 
has also been linked to dopamine receptors [8,9), and has been isolated as a 
binding partner of the dopamine transporter (DAT; [10]). These studies report a role 
for Rasgrf2 both pre- and post-synaptically, indicating a preferential role of Rasgrf2 in 
the regulation of synaptic transmission and plasticity. 
RASGRF2 has recently been implicated as a novel candidate in the regulation 
of alcohol consumption via dopaminergic signalling in the mesolimbic system [5]. A 
genome wide analysis of 28,188 people found polymorphisms of RASGRF2 to be 
significantly associated with alcohol consumption. The same study reported that 
Rasgrf2 knock-out (KO) mice consume significantly less alcohol and have a reduced 
alcohol preference compared to their wild-type (WT) counterparts. Rasgrf2 KO mice 
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do not experience dopamine increases in the nucleus accumbens (ventral striatum) 
after an alcohol challenge compared to wild type (WT) mice, suggesting that Rasgrf2 
KO mice do not experience the motivationally rewarding properties of alcohol to the 
same extent as WT mice [5].  
Previous studies have shown no difference in Rasgrf2 expression up to six 
hours following acute cocaine [11] and amphetamine [12] administration at several 
doses in the ventral- and dorsal striatum, as well as in other areas of the forebrain 
including the medial prefrontal cortex and the hippocampus. Both cocaine and 
amphetamine did however produce the behavioural activating effects typically 
associated with these drugs such as increased locomotion and sniffing and biting 
behaviours [11,12]. These studies also report alterations in Rasgrf1 expression in 
these regions, highlighting the heterogeneity of these two isoforms in synaptic 
plasticity. Acute injection of cocaine [13-17] and amphetamine [14,15,18-20] 
increase phosphorylation of ERKs in the striatum. In contrast, moderate blood 
alcohol levels reduce ERK phosphorylation in brain regions including the amygdala, 
cerebellum, hippocampus, frontal cortex and dorsal striatum. However, during 
alcohol withdrawal increases in ERK phosphorylation have been reported [21]. The 
present study aimed to further investigate the role Rasgrf2 in the regulation of 
dopaminergic activity after alcohol treatment.  
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2. Material and Methods 
All housing and experimental procedures were performed in accordance with the 
U.K. Home Office Animals (Experimental Procedures) Act 1986.  
 
2.1. Animals 
Male WT (+/+) and null mutant (-/- KO) Rasgrf2tm1Esn [22] mice were studied. Mice 
were generated using a gene targeting strategy and subsequently kept on a genetic 
background of 129/S-J and C57BL/6, detailed methods as previously described [22]. 
The method inactivates the Grf2 locus by targeting its CDC25-H catalytic domain, 
thereby disrupting the guanine nucleotide exchange factor (GEF) activity of Rasgrf2. 
Animals were individually housed, provided with food and water ad libitum, and kept 
on a 12:12 hour light: dark cycle (lights on at 7.00 am). Experiments were performed 
during the light cycle between 09:00 and 16:00 h, in a pseudorandom order. Room 
temperature was maintained between 19°C and 22°C at a humidity of 55% (±10%). 
Animals were housed in Tecniplast cages (32cm x 16cm x 14cm), using Litaspen 
sawdust and nesting materials, (Sizzlenest, Datsand, Manchester UK).  
 
2.2. In vivo microdialysis 
Mice were deeply anaesthetised (detailed methods as previously described [23]) and 
a guide cannula (Microbiotech/se AB, Stockholm, Sweden) was aimed at the DStr 
(A: +0.5; L: ±2.3; V: -2.4 angle ±10º from midline) using coordinates relative to 
bregma [24]. On the day of the experiment, a microdialysis probe of a concentric 
design, membrane length of 2mm (MAB 6.14.2.), was inserted into the guide cannula 
under a short (3-5min) Isoflurane anaesthesia (O2 at 1L/min, Isoflurane at 3% to 
induce and 2% to sustain). Samples were collected every 20 minutes. Three 
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samples were taken during the first testing hour of the experiment to measure 
baseline quantities of DA [25]. An injection of alcohol was then administered i.p. 
(2g/kg, vinj= 10 ml/kg). A further nine samples were collected. All samples were 
analysed using HPLC-ED (as described [25, 26]) to measure DA levels in response 
to alcohol administration. Alcohol naïve male mice were used for this test (Rasgrf2 
KO: n=8; Rasgrf2 WT: n=8). In-vivo microdialysis was carried out at least 5 days 
after surgery on day one of the experiment during which animals received an alcohol 
injection (2g/kg, i.p.). This provided an acute neurochemical response to alcohol 
treatment. Once microdialysis experiments were complete, animals were sacrificed 
by cervical dislocation. Brains were fixed in 4% formaldehyde solution and stored at 
4 °C. Brains were sliced on a microtome and stained with cresyl violet for analysis of 
probe placement. Only animals with probe placement within the DStr were 
considered for data analysis. Since all probes were surgically inserted accurately 
within the DStr, all animals were considered for data analysis. 
 
2.3. Gene Expression 
In order to investigate whether expression of dopaminergic genes involves Rasgrf2, 
we measured mRNA expression profiles of the dopamine transporter (DAT), 
dopamine receptor regulating factor (DRRF), and dopamine D2 receptor (DRD2) in 
the frontal cortex (FC), ventral striatum (VStr), dorsal striatum (DStr), hippocampus 
(Hipp), and the cerebellum (Cer) of Rasgrf2 KO and WT mice after sub-chronic 
treatment with either saline or alcohol. In order to test whether peripheral (blood) 
gene expression would be predictive for brain adaptations, we also measured mRNA 
expression in the blood and performed a correlation analysis with specific brain 
areas. Single housed Rasgrf2 KO and WT mice (n=8-9/group) received a daily i.p. 
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injection with either alcohol (3.5 g/kg) or saline for 7 days. After each injection 
animals were placed back to their home cages. 120 minutes after the last injection, 
animals were sacrificed by cervical dislocation and the brain and spleen were 
removed and immediately cooled on dry ice. Tissue was kept at -80 degree until 
further analysis. The frozen brain was placed on a cold dissecting surface and it was 
hemisected by cutting in the sagittal plane. Brain areas were dissected according to 
Paxinos and Franklin [27]. As previously described [28], total RNA was extracted 
using a modified Qiagen-protocol: A phenol-extraction in Qiazol (Qiagen) was 
followed by column-purification with Rneasy Mini Kit (Qiagen), including DNase 
digestion according to manufacturer’s protocol. cDNA was synthesized using iScript 
cDNA Synthesis Kit (Biorad, Munich/Germany) following manufacturer’s instructions. 
Quantitative rt-PCR was performed using SYBR Green I Master Mix buffer (Applied 
Biosystems), and reactions were run on an iCycler (Roche) using a three-step 
standard protocol. The annealing temperature was optimized for all primer pairs and 
ranged from 55 to 65 C°. PCR products were visualized on standard 2% agarose 
gels with ethidium bromide to eliminate the possibility of having amplified genomic 
DNA. beta-Actin was used as internal standard, and CT values were calculated from 
differences between beta-Actin and the target genes. All experiments were repeated 
at least three times and the mean value used for further analysis. 
 
The following primer pairs were used: 
Β-Actin-F: CTGTATTCCCCTCCATCGTG 
Β-Actin-R: GAAGATCTGGCACCACACCT 
DRD2-F: TGGACTCAACAACACAGACCAGAATG 
DRD2-R: GATATAGACCAGCAGGGTGACGATGA 
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DRRF-F: CAAAAGCCACCGCTGTCCCTTC 
DRRF-R: GGCGAACTTCTTGTCACAGCCA 
DAT-F: ATCAACCCACCGCAGACACCAGT 
DAT-R: CTTTCAGGACAGGGCAG 
 
2.4. Statistical Analysis 
All graphical output data is expressed as a mean ± SEM. Microdialysis: Baseline 
neurochemical data were analysed using one way ANOVA. Alcohol induced 
neurochemical effects were expressed as a percentage of the mean of the three 
baseline samples which were taken as 100% to standardise the data across groups. 
Data were compared using two-way ANOVA with factors genotype (2) and time (13). 
To compare alcohol effects of certain time points, pre-planned t-test point-by-point 
comparisons were performed. Gene expression: The mRNA expression was 
calculated as deltaCT (mean+SEM). For statistical analysis, two-way ANOVAs with 
factors genotype (2) and treatment (2) were used. To evaluate genotype effects on 
single brain area and blood level, planned comparisons using Bonferroni-corrected 
Fisher’s LSD test were calculated. A correlation analysis of brain and blood mRNA 
expression (Pearson correlation) was performed for all target mRNA with pooled 
genotypes. The software used was Statistica 7.0. A significance level of p <0.05 was 
used to test for statistical significance.  
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3. Results 
3.1. No alcohol-induced dopamine response in the dorsal striatum of Rasgrf2 
KO mice  
Resting DA levels in alcohol naïve Rasgrf2 KO and WT mice were comparable 
between groups in the DStr (F1,38 =0.06, p=0.80; Fig. 1A). An acute alcohol treatment 
increase extracellular DA levels in WT animals. This effect was absent in Rasgrf KO 
mice. A two-way ANOVA showed significant effects of time (F12,84 =2.71, p=0.004) 
and genotype (F1,7=6.63, p=0.04), but no significant interaction (F12,84 =1.37, p=0.20; 
Fig 1B). Wild type DA levels in response to an alcohol injection were significantly 
different from Rasgrf2 KO mice 120 min (p=0.04) and 140 min (p=0.04) after 
administration (Fig. 1B).  
 
3.2. Alcohol treatment reduced DAT and DRRF expression in several brain 
regions of Rasgrf2 KO mice  
There was no difference in DAT mRNA expression between Rasgrf2 KO and WT 
mice after saline treatment across all brain areas (Fig 2A). After alcohol treatment 
DAT mRNA expression in Rasgrf2 KO mice decreased relative to WT mRNA 
expression levels (higher deltaCT; Fig 2B). There was a significant effect of 
genotype in the FC (F1, 34=4.06, p=0.05), but not of treatment or interaction (p>0.05). 
In the VStr, there was a significant genotype effect (F1,34=5.49, p<0.025), but no 
significant effects of treatment or of interaction (p>0.05). In the DStr there were no 
significant effects (p>0.05). There was a significant effect of genotype (F1,34=17.41, 
p=0.0002), treatment (F1,34=20.06, p=0.00008), and interaction (F1,34=6.20, 
p=0.0178) in the Hipp. In the Cer, there was a significant effect of genotype 
(F1,34=5.69, p=0.023) and an interaction (F1,34=6.02, p=0.019), but no significant 
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treatment effect (p>0.05). Post hoc Fisher’s LSD tests revealed a significant 
difference between Rasgrf2 KO and WT mice after alcohol treatment in the FC 
(p=0.03), VStr (p=0.026), Hipp (p< 0.0001), and Cer (p=0.0026), but not in the DStr 
(p>0.05).  
There was no difference in DRRF mRNA expression between Rasgrf2 KO and WT 
mice after saline treatment across all brain areas (Fig 2C). After alcohol treatment, 
DRRF mRNA expression in Rasgrf2 KO mice decreased relative to WT mRNA 
expression levels (higher deltaCT; Fig 2D). There was a significant effect of 
genotype in the FC (F1, 34=5.90, p<0.0205), but not of treatment or interaction 
(p>0.05). In the VStr, there was a significant genotype (F1,34=12.60, p<0.0012) and 
treatment effect (F1,34=5.38, p=0.0265), but no significant interaction (p>0.05). In the 
DStr, there was a significant genotype effect (F1,34=4.42, p=0.04), but not of 
treatment or interaction (p>0.05). There were no significant effects in the Hipp 
(p>0.05). In the Cer, there was a significant effect of genotype only (F1,34=6.80, 
p=0.0134). Post hoc Fisher’s LSD tests revealed a significant difference between 
Rasgrf2 KO and WT mice after alcohol treatment in the FC (p=0.024), VStr 
(p=0.0003), DStr (p=0.0192), and Cer (p=0.0168), but not in the Hipp (p>0.05).  
There were no genotype differences in DRD2 mRNA expression after either saline 
(Fig 2E) or alcohol (Fig 2F) treatments across all brain areas measured in the 
present study (p>0.05). Levels of DAT, DRRF and DRD2 in the blood after both a 
saline injection and an alcohol injection were not significantly different between 
Rasgrf2 KO and WT mice. 
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3.3. Correlations in the mRNA expression profiles 
Co-expression analysis showed that there was a positive relationship in DAT mRNA 
expression between specific brain areas and blood. A strong correlation was seen 
between spleen vs. FC (r=0.75; p<0.0001; Fig 3A) and spleen vs. Cer (r=0.77; 
p<0.0001; Fig 3E). A significant correlation was also found for spleen vs. VStr 
(r=0.49; p=0.002; Fig 3B), spleen vs. DStr (r=0.52; p=0.001; Fig 3C), and spleen vs. 
Hipp (r=0.44; p=0.005; Fig 3D). FC and blood expression of DRRF was also 
positively correlated, although the nature of this relationship was rather weak 
(r=0.33; p=0.042; Fig 3F). DRD2 mRNA expression was also positively correlated 
between brain and blood. There was a relationship seen spleen vs. FC (r=0.44; 
p=0.006; Fig 3G), spleen vs. VStr (r=0.42; p=0.009; Fig 3H), spleen vs. Hipp (r=0.47; 
p=0.003; Fig 3I), and between spleen vs. Cer (r=0.60; p<0.0001; Fig 3J). 
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4. Discussion 
In order to experience the acute reinforcing effects of alcohol, several 
neurotransmitter systems in the reward centres of the brain are recruited [29,30]. 
Changes in DA levels in the NAcc in response to an alcohol challenge, is an 
indicator of the incentive properties of alcohol [31,32]. Previous work suggests that 
Rasgrf2 is not implicated in the striatum following acute drug action of cocaine [11] 
and amphetamine [12] exposure. However, the absence of an alcohol-induced DA 
increase in the NAcc of Rasgrf2 KO mice may contribute towards a diminished 
alcohol consumption and preference [5]. Rasgrf2 has been shown to mediate these 
responses via the dopaminergic neurons of the ventral tegmental area [5]. In 
addition, polymorphisms in the human RASGRF2 gene have been associated with 
alcohol intake [5] and changes in brain structure, including the medial prefrontal 
cortex, in an elderly human population [33]. The present study aimed to further 
characterize how Rasgrf2 regulates dopaminergic mechanisms in the DStr in 
response to alcohol administration. In contrast to the NAcc [5], present data revealed 
no differences in DA baseline levels between Rasgrf2 KO and WT mice in the DStr. 
When challenged with alcohol, extracellular DA levels in the DStr increased in WT 
mice, but remained at basal levels in the Rasgrf2 KO mice. These data complement 
previous research by Stacey and colleagues [5] which revealed the absence of a DA 
response in Rasgrf2 KO mice in the NAcc. Together, past and present data suggest 
that aberrant DA activity in the ventral striatum, in particular the Nacc and dorsal 
striatum of Rasgrf2 KO mice may account for the abated motivational and rewarding 
effects of alcohol. This acute effect may impact upon subsequent alcohol 
consumption and preference behaviours in these mice. 
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Rasgrf2 has been isolated as a binding partner of the DAT [10], the primary 
mechanism for synaptic DA clearance in the striatum. The RAS-MAPK/ERK pathway 
has also been associated with dopamine receptors [8,9]. These studies suggest an 
important role for Rasgrf2 at the synapse in the regulation of reinforcement via 
dopaminergic signalling [10]. Brain expression analysis indicated no differences in 
DAT, DRRF or DRD2 between Rasgrf2 KO and WT mice after a saline injection, 
indicating that Rasgrf2 has no role in the control of DAT, DRRF, and DRD2 
expression under basal conditions. After sub-chronic alcohol administration, there 
was no difference between genotypes in DRD2 mRNA expression levels. However, 
DAT and DRRF mRNA expression decreased in Rasgrf2 KO relative to WT mice. 
Rasgrf2 is partially responsible for the regulation of DAT [10]. Decreased DAT 
expression in the FC, VStr, Hipp, and Cer of the Rasgrf2 KO mice in the present 
study would suggest a reduced DA reuptake from the synaptic cleft, and thus 
enhanced extracellular DA levels in comparison to WT mice in these areas. This 
view is supported by previous microdialysis data from Stacey and colleagues [5] 
which showed enhanced DA levels in the Nacc of Rasgrf2 mice at basal conditions 
and a reduced DA response after an alcohol challenge. These findings also suggest 
that basal DA levels appear to be under different Rasgrf2-DAT mediated control in 
the DStr vs. VStr.   
Significant decreases in DRRF expression in Rasgrf2 KO mice were seen in the FC, 
VStr, DStr, and Cer compared to WT mice in response to an alcohol challenge. 
DRRF is a transcription factor and regulates transcription for a number of different 
promoters. DRRF is important for modulating dopaminergic transmission in the brain 
and can alter DA receptor expression [34]. DRRF is known to regulate the DRD2 
gene as well as the DRD1A and DRD3 promoters [34]. Acute cocaine administration 
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has been shown to produce a large extracellular DA increase which in turn produces 
a decrease in DRRF mRNA levels in the NAcc core and shell [35]. Conversely, 
caffeine produces a much smaller increase in DA levels in the striatum and does not 
alter DRRF mRNA [35]. These data are in keeping with the suggested role of DRRF 
as a DA receptor regulator [36]. DRRF has the potential to be a contributing 
mechanism in the DStr in the mediation of DA concentration in the synaptic cleft 
following acute alcohol administration in the present study. We also quantified DRD2 
mRNA expression in the DStr, but there were no significant differences between 
Rasgrf2 KO and WT mice. This suggests that DRRF does not alter DRD2 
expression, but may act via DRD1 or DRD3 instead. The RAS-MAPK/ERK pathway 
has also been associated with DRD1 [8,9] and could be the mediating mechanism in 
the current study. In addition, alcohol-induced adaptations in the noradrenergic and 
serotonergic systems appear under the control of Rasgrf2, which may also contribute 
to the observed phenotype [37].  
Co-expression analysis indicated a positive relationship in DAT mRNA expression 
between all brain areas and blood, with particularly strong correlations in the FC and 
Cer. The nature of the correlation between blood and brain FC DRRF was positive 
although a rather weak association. DRRF showed no correlation in either the DStr 
or VStr. Expression of DRD2 showed a weak but significant correlation between 
blood and brain in all areas except the DStr. This may help to predict mRNA 
expression changes in response to alcohol administration in the brain by using 
respective markers in the blood.  
 
5. Conclusions 
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Present data provide further evidence for a distinct contribution of Rasgrf2 in 
dopaminergic signaling in the dorsal striatum and suggests that Rasgrf2 may 
mediate dopaminergic adaptations to alcohol in mice.  
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Figure Legends 
 
Figure 1: Extracellular dopamine (DA) levels in the dorsal striatum (DStr) of Rasgrf2 
knock-out (KO) and wild-type (WT) mice. (A) Baseline DA levels prior to alcohol 
treatment. (B) DA levels in response to an alcohol challenge. The arrow indicates the 
time of alcohol treatment (*p<0.05, WT vs. Rasgrf2 KO). 
 
Figure 2: The effects of alcohol treatment (3.5 g/kg, i.p., 7d) on mRNA expression in 
the brain of Rasgrf2 knock-out (KO) and wild-type (WT) mice (DAT- dopamine 
transporter, DRRF-dopamine receptor regulating factor, DRD2- dopamine D2 
receptor; FC-frontal cortex, VStr–ventral striatum, DStr–dorsal striatum, Hipp-
hippocampus, Cer-cerebellum; *p<0.05, **p<0.01, ***p<0.001). 
 
Figure 3: The blood mRNA expression correlates with brain area expression in 
Rasgrf2 knock out and wild type mice after alcohol (3.5 g/kg, i.p., 7d) and saline 
treatment. Data pooled for genotype and treatment (DAT- dopamine transporter, 
DRRF-dopamine receptor regulating factor, DRD2 – dopamine D2 receptor). 
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